ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
11.13
-0.03 (-0.27%)
Mar 23, 2026, 4:00 PM EDT - Market closed
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $1.12 billion as of March 23, 2026. Its market cap has increased by 100.33% in one year.
Market Cap
1.12B
Enterprise Value
842.94M
1-Year Change
100.33%
Ranking
Category
Stock Price
$11.13
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $1.12B, an increase of 50.54%. That is a compound annual growth rate of 7.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.12B | 40.59% |
| Dec 31, 2025 | 796.64M | 39.89% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Olema Pharmaceuticals | 1.23B |
| Kodiak Sciences | 1.18B |
| MoonLake Immunotherapeutics | 1.17B |
| Precigen | 1.16B |
| Corvus Pharmaceuticals | 1.12B |
| EyePoint | 1.10B |
| Damora Therapeutics | 1.09B |
| Septerna | 1.09B |